A detailed history of Focus Financial Network Inc /Adv transactions in Cassava Sciences Inc stock. As of the latest transaction made, Focus Financial Network Inc /Adv holds 15,921 shares of SAVA stock, worth $422,224. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,921
Holding current value
$422,224
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$12.64 - $30.11 $201,241 - $479,381
15,921 New
15,921 $358 Million

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.06B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Focus Financial Network Inc /Adv Portfolio

Follow Focus Financial Network Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focus Financial Network Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Focus Financial Network Inc /Adv with notifications on news.